HEALTH
From Times Staff and Wire Reports
ICN Beats Back Khan’s Proxy Challenge: The Costa Mesa-based drug company easily won a bitter 10-month proxy battle as dissident investor Rafi M. Khan garnered less than 10% of the votes cast at the firm’s annual meeting on his proposal to oust Chairman Milan Panic and eight other board members. ICN said it will pursue legal action against Khan unless he reimburses the company for the $4 million it spent defending itself.
